Status:
COMPLETED
Interest of S100B Protein for Patient Victim of Minor Traumatic Brain Injury and Treated by Antiplatelet
Lead Sponsor:
Poitiers University Hospital
Conditions:
Minor Traumatic Brain Injury
Treatment by Antiplatelet
Eligibility:
All Genders
18+ years
Phase:
PHASE3
Brief Summary
All the patients admitted in emergency department for minor traumatized cranial, with antiplatelet therapy, can be included, after checked inclusion and non inclusions criterias. If they are agree, a ...
Eligibility Criteria
Inclusion
- Age \> 18 Years old
- Minor traumatic brain injury measured by a Glasgow score between 13 and 15
- Antiplatelet agent therapy
- Free subject without tutorship or curatorship
Exclusion
- Age \< 18 years old
- Glasgow score \<13
- Traumatic brain injury older than 6 hours
- Patient without any social security system
- Patient with renforced protection (tutorship, curatorship, …)
Key Trial Info
Start Date :
January 25 2019
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
October 28 2025
Estimated Enrollment :
720 Patients enrolled
Trial Details
Trial ID
NCT03780062
Start Date
January 25 2019
End Date
October 28 2025
Last Update
December 29 2025
Active Locations (4)
Enter a location and click search to find clinical trials sorted by distance.
1
CHU of MONTPELLIER
Montpellier, France, 34090
2
CHU of NICE
Nice, France, 06003
3
La Pité Salpêtrière
Paris, France, 75013
4
CHU of POITIERS
Poitiers, France, 86021